P-615 Phase II trials of gefitinib (‘Iressa’, ZD1839): rapid and durable objective responses in patients with advanced non-small-cell lung cancer (IDEAL 1 and IDEAl 2)
- 1 August 2003
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 41, S247-S248
- https://doi.org/10.1016/s0169-5002(03)92582-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: